PMID: 9449298Jan 1, 1997Paper

Initial experience with the modified vaginal wall sling in the treatment of female stress urinary incontinence

International Urogynecology Journal and Pelvic Floor Dysfunction
A K BatraA Lopresti

Abstract

From March 1995 to March 1996 24 women aged 29-73 years with stress urinary incontinence underwent a modified vaginal wall sling procedure following videourodynamic evaluation. Of these 24, 2 had stress urinary loss due to urethral hypermobility (UH), 3 had intrinsic sphincter deficiency (ISD) and 19 had both UH and ISD. Thirteen (54%) had preoperative urge incontinence, 13 (54%) had associated pelvic floor weakness, including cystocele, and 12 (50%) had had previous pelvic surgery and bladder neck suspension. Twenty-two patients were evaluable for a mean follow-up of 14 months (range 9-21 months). Stress urinary incontinence was resolved in all patients (100%). Of the patients with preoperative urge symptoms, 58% reported resolution but in 42% the urge symptoms remained unresolved. One new patient developed urge and occasional urge incontinence. Out of 22 patients 20 (90.9%) are totally continent; 2 (9.1%) are incontinent and both have documented detrusor instability and occasionally wear pads. The vaginal wall sling is an ideal procedure for the treatment of the various forms of stress urinary incontinence in women. In our series the early results indicate excellent patient acceptability and continence. Long-term follow-up wi...Continue Reading

References

Sep 1, 1992·The Journal of Urology·S RazV W Nitti
May 1, 1992·Urology·S JumaS Raz
Oct 1, 1991·Urology·H CammuJ J Amy
Jun 1, 1991·The Journal of Urology·J G Blaivas, B Z Jacobs
Apr 1, 1988·The Journal of Urology·J G Blaivas, C A Olsson
Jul 1, 1995·American Journal of Obstetrics and Gynecology·A Bergman, G Elia
Aug 1, 1995·British Journal of Urology·A K MongaS L Stanton
Jul 1, 1994·American Journal of Obstetrics and Gynecology·G W Davila, K V Ostermann
Jul 1, 1993·Obstetrical & Gynecological Survey·G Elia, A Bergman
Apr 1, 1993·The Journal of Urology·V W NittiS Raz
Mar 1, 1953·American Journal of Obstetrics and Gynecology·C P HODGKINSON

❮ Previous
Next ❯

Citations

May 16, 2009·International Urogynecology Journal and Pelvic Floor Dysfunction·Marijke C Ph Slieker-ten HoveMark E Vierhout
Dec 20, 2000·American Journal of Obstetrics and Gynecology·A M Weber, M D Walters
May 16, 2000·São Paulo Medical Journal = Revista Paulista De Medicina·C A Bezerra, M V Sadi
Nov 6, 2009·Planta·Britta HartardMichael Lakatos
Dec 17, 1997·The Journal of Clinical Endocrinology and Metabolism·S R BornsteinL Engelmann
Nov 7, 2001·The Journal of Urology·H B GoldmanR A Appell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.